A synergistic pharmaceutical combination for the treatment of cancer
A novel pharmaceutical combination comprising a cytotoxic antineoplastic agent selected from a the group consisting of paclitaxel, docetaxel, doxorubicin and gemcitabine or a pharmaceutically acceptable salt thereof and at least one cyclin dependent kinase (CDK) inhibitor; wherein the said combinati...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English |
Published |
20.11.2008
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A novel pharmaceutical combination comprising a cytotoxic antineoplastic agent selected from a the group consisting of paclitaxel, docetaxel, doxorubicin and gemcitabine or a pharmaceutically acceptable salt thereof and at least one cyclin dependent kinase (CDK) inhibitor; wherein the said combination exhibits synergistic effects when used in the treatment of cancer. The invention also relates to a method for the treatment of cancer, using a therapeutically effective amount of the said combination. |
---|---|
Bibliography: | Application Number: AU20070353129 |